P

PT Pyridam Farma Tbk

IDX-PYFA
Indonesia Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#17820
Country Rank
#217
Market Cap
$302.12 M
Price
$0.0282
Change (%)
5.00%
Volume
39.65 M

PT Pyridam Farma Tbk's latest marketcap:

$302.12 M

As of 08/06/2025, PT Pyridam Farma Tbk's market capitalization has reached $302.12 M. According to our data, PT Pyridam Farma Tbk is the 17820th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap $302.12 M
Revenue (ttm) $177.14 M
Net Income (ttm) $-27,609,251.76
Shares Out 11.24 B
EPS (ttm) $0
Forward PE 0.00
Ex-Dividend Date 05/30/2017
Earnings Date 08/01/2025
Market Cap Chart
Data Updated: 08/06/2025

PT Pyridam Farma Tbk's yearly market capitalization.

PT Pyridam Farma Tbk has seen its market value grow from Rp72.24 B to Rp4.94 T since 2014, representing a total increase of 6,744.45% and an annual compound growth rate (CAGR) of 48.98%.
Date Market Cap(Rp) Market Cap(USD) Change (%) Global Rank
08/06/2025 Rp4.94 T $302.12 M 109.52% 17820
12/30/2024 Rp2.36 T $141.58 M 285.15% 21103
12/29/2023 Rp612.67 B $42.89 M 32.37% 28820
12/30/2022 Rp462.84 B $27.77 M -14.78% 30739
12/30/2021 Rp543.11 B $38.02 M 4.1% 29217
12/30/2020 Rp521.7 B $36.52 M 392.42% 26493
12/30/2019 Rp105.95 B $7.42 M 4.76% 29753
12/28/2018 Rp101.13 B $7.08 M 3.28% 28869
12/29/2017 Rp97.92 B $6.85 M -8.5% 28495
12/30/2016 Rp107.02 B $7.49 M 78.57% 26004

Company Profile

Company Overview

PT Pyridam Farma Tbk is a pharmaceutical company specializing in the development, production, and trading of medical products primarily in Indonesia. Founded in 1976 and headquartered in Jakarta Selatan, the company operates under its parent company, Rejuve Global Investment Pte. Ltd.

Business Segments

  • Pharmaceutical Products, Esthetic, and Toll Manufacturing Services
  • Medical Equipment

Product Offerings

Medical Instruments & Equipment:

  • Clinical waste, collection swabs, and tubes
  • KF94 masks, parafilm, and PCR extraction kits
  • Specimen bags, sterile containers, and PCR machines

Skin Care Products:

  • Arosa gel, A-Stark Gel, Hymen gel
  • Pyderen Emulsion, Tonic Bust Emulsion
  • Calmosan Cream, Di-Herb gel

Pharmaceutical & Health Products:

  • Over-the-counter, ethical, and sigma products
  • Mineral supplements, vitamins, and consumer health products
  • Sanitizers and antiseptics

The company serves various therapeutic areas, including musculoskeletal, cardiovascular, genitourinary, and respiratory systems.

Frequently Asked Questions

  • What is PT Pyridam Farma Tbk's (IDX-PYFA) current market cap?
    As of 08/06/2025, PT Pyridam Farma Tbk (including the parent company, if applicable) has an estimated market capitalization of $302.12 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • PT Pyridam Farma Tbk global market capitalization ranking is approximately 17820 as of 08/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.